APA (7th ed.) Citation

Robison, T. W., Heflich, R. H., Manjanatha, M. G., Elespuru, R., Atrakchi, A., Mei, N., & Ding, W. (2021). Appropriate in vivo follow-up assays to an in vitro bacterial reverse mutation (Ames) test positive investigational drug candidate (active pharmaceutical ingredient), drug-related metabolite, or drug-related impurity. Mutation research. Genetic toxicology and environmental mutagenesis, 868-869, 503386. https://doi.org/10.1016/j.mrgentox.2021.503386

Chicago Style (17th ed.) Citation

Robison, Timothy W., Robert H. Heflich, Mugimane G. Manjanatha, Rosalie Elespuru, Aisar Atrakchi, Nan Mei, and Wei Ding. "Appropriate in Vivo Follow-up Assays to an in Vitro Bacterial Reverse Mutation (Ames) Test Positive Investigational Drug Candidate (active Pharmaceutical Ingredient), Drug-related Metabolite, or Drug-related Impurity." Mutation Research. Genetic Toxicology and Environmental Mutagenesis 868-869 (2021): 503386. https://doi.org/10.1016/j.mrgentox.2021.503386.

MLA (9th ed.) Citation

Robison, Timothy W., et al. "Appropriate in Vivo Follow-up Assays to an in Vitro Bacterial Reverse Mutation (Ames) Test Positive Investigational Drug Candidate (active Pharmaceutical Ingredient), Drug-related Metabolite, or Drug-related Impurity." Mutation Research. Genetic Toxicology and Environmental Mutagenesis, vol. 868-869, 2021, p. 503386, https://doi.org/10.1016/j.mrgentox.2021.503386.